Sharp Therapeutics Corp (SHRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | |
| Operating Expenses | 4,552 | 2,268 |
| Operating Income | -4,552 | -2,268 |
| Interest Expense | 171 | 174 |
| Other Income | 1,462 | -1,123 |
| Pre-tax Income | -3,261 | -3,565 |
| Net Income Continuous | -3,261 | -3,565 |
| Net Income | $-3,261 | $-3,565 |
| EPS Basic Total Ops | -3.60 | -0.13 |
| EPS Basic Continuous Ops | -3.60 | N/A |
| EPS Diluted Total Ops | -3.60 | -0.13 |
| EPS Diluted Continuous Ops | -3.60 | N/A |
| EBITDA(a) | $-2,989 | $-3,276 |